natgillin/translations-raw huggingface dataset:
In hypertensive patients with one or more additional risk factors for cardiovascular disease, doxazosin prolonged release tablets should not be used as a single agent for the first-line treatment of hypertension due to a possible increased risk for development of heart failure. 
Tablete doksazosina s podaljšanim sproščanjem se zaradi morebitnega povečanega tveganja za nastanek srčne odpovedi ne smejo uporabljati kot prvo zdravilo izbora za samostojno zdravljenje hipertenzije pri bolnikih s hipertenzijo in enim ali več dejavniki tveganja za nastanek kardiovaskularnih bolezni.
Winthrop Pharmaceuticals UK Ltd 1 Onslow Street, Guildford, Surrey GU1 4YS United Kingdom Tel: 00 44 (0) 1483 55 4831 Fax: 00 44 (0) 1483 55 4831 
Winthrop Pharmaceuticals UK Ltd 1 Onslow Street, Guildford, Surrey GU1 4YS Združeno kraljestvo Tel: 00 44 (0) 1483 55 4831 Faks: 00 44 (0) 1483 55 4831
Uncommon: flushing, fever/shiver, paleness Rare: low body temperature in elderly 
Občasni: vročinski oblivi, zvišana telesna temperatura/mrzlica, bledost Redki: nizka telesna temperatura pri starejših bolnikih
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]are available in blister packs of 28, 30 and 100 tablets. 
Zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena je na voljo v pretisnih omotih po 28, 30 in 100 tablet.
Special care should be taken with hypotensive patients or patients with known orthostatic dysregulation taking doxazosin prolonged release tablets to treat benign prostatic hyperplasia (BPH). 
Pri hipotenzivnih bolnikih ali bolnikih z znano ortostatsko disregulacijo, ki jemljejo tablete doksazosina s podaljšanim sproščanjem za zdravljenje benigne hiperplazije prostate (BPH), je treba biti posebno previden.
Before surgery or anaesthesia even at the dentist, you should tell the doctor or the dentist that you are taking {Invented name}. 
Pred kirurškim posegom in anestezijo, tudi pri zobozdravniku, morate zdravniku ali zobozdravniku povedati, da jemljete zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena.
Winthrop Pharmaceuticals UK Ltd 1 Onslow Street, Guildford, Surrey GU1 4YS United Kingdom Tel: 00 44 (0) 1483 55 4831 Fax: 00 44 (0) 1483 55 
Winthrop Pharmaceuticals UK Ltd 1 Onslow Street, Guildford, Surrey GU1 4YS Združeno kraljestvo Tel: 00 44 (0) 1483 55 4831 Faks: 00 44 (0) 1483 55
Like all medicines, Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]can cause side effects, although not everybody gets them. 
Kot vsa zdravila lahko tudi zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena povzroči neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Microcrystalline cellulose Povidone α-tocopherol 
Povidon α-tokoferol
Do not change the dose or stop taking your tablets unless you have spoken to your doctor. 
Izberite si čas, ki vam ustreza, in jih jemljite ob tem času vsak dan. Ne spremenite odmerka in ne prenehajte jemati tablet, dokler se ne posvetujete z zdravnikom.
Blood and the lymphatic system disorders: Very rare: Reduction of erythrocytes, leucocytes and thrombocytes 
Zelo redki: zmanjšanje števila eritrocitov, levkocitov in trombocitov
• if you are suffering from liver disease 
• če imate bolezen jeter;
Uncommon effects, seen in more than 1 out of 1,000 patients but less than 1 in 100 patients, include low levels of potassium in the blood, gout, increased thirst, nightmares, forgetfulness (amnesia), emotional instability, tremor, muscle stiffness, increased tear production, abnormal intolerance to light, ringing in the ears (tinnitus), heart flutters, angina pectoris, an increase or slowing of the heart rate, heart attack, low blood pressure especially on getting up from a sitting or lying position, reduced blood supply to the limbs, dizziness on standing (syncope), nose bleeds, tightening of the chest, cough, throat inflammation, lack of appetite or increased appetite, taste disturbances, hair loss, swelling of the face and joints, muscle pain, swelling of joint and pain (arthralgia), muscle weakness, incontinence, difficulty with or pain on urinating, flushing, fever (shivers) and loss of colour. 
Med občasnimi neželenimi učinki, ki so jih opazili pri več kot 1 bolniku od 1000, vendar manj kot 1 bolniku od 100, so nizke ravni kalija v krvi, protin, povečana žeja, nočne more, pozabljivost (amnezija), čustvena nestabilnost, tresenje, otrdelost mišic, povečano solzenje, nenavadna preobčutljivost za svetlobo, zvenenje v ušesih (tinitus), srčna undulacija (plapolanje), angina pektoris, pospešeno ali upočasnjeno bitje srca, srčna kap, nizek krvni pritisk, zlasti pri vstajanju iz sedečega ali ležečega položaja, zmanjšan dovod krvi v okončine, vrtoglavica ob vstajanju (sinkopa), krvavitve iz nosu, stiskanje v prsnem košu, kašelj, vnetje grla, zmanjšanje ali povečanje apetita, motnje okušanja, izguba las, otekanje obraza in sklepov, bolečine v mišicah, zatekanje in bolečina v sklepih (artralgija), mišična šibkost, inkontinenca, težave ali bolečine pri uriniranju, vročinski oblivi, zvišana telesna temperatura (mrzlica) in bledica.
• If you have any kind of congestion or blockage in your urinary tract, an infection of the urinary tract or have bladder stones 
• če imate kakršno koli obliko zastoja ali zapore sečil, kronično vnetje sečil ali kamne v mehurju;
Butylhydroxytoluene (E321) Colloidal anhydrous silica Sodium stearyl fumarate 
Butilhidroksitoluen (E 321) Silicijev dioksid, koloidni, brezvodni Natrijev stearilfumarat
Administration of Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]to patients with prostatic hyperplasia results in a significant improvement in urodynamics and symptoms as a result of a selective blockade of alpha-adrenoceptors located in the prostatic muscular stroma, capsule and bladder neck. 
Uporaba zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena pri bolnikih s hiperplazijo prostate pomembno izboljša urodinamiko in simptome zaradi selektivnega blokiranja alfa-adrenergičnih receptorjev v stromi prostate, kapsuli in vratu mehurja.
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]can be used as sole agent or in combination with another medicinal product e.g. a thiazide diuretic, beta-adrenoceptor blocking agent, calcium antagonist or an ACE-inhibitor. 
Zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena se lahko uporablja samostojno ali v kombinaciji z drugimi zdravili, npr. tiazidnimi diuretiki, blokatorji beta-adrenergičnih receptorjev, kalcijevimi antagonisti ali zaviralci ACE.
Children and adolescents: Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]is not recommended for use in children and adolescents due to a lack of clinical experience. 
Otroci in mladostniki: Uporaba zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena se pri otrocih zaradi pomanjkanja kliničnih izkušenj ne priporoča.
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]may influence plasma renin activity and urinary excretion of vanillylmandelic acid. 
Zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena lahko vpliva na aktivnost renina v plazmi in izločanje vanililmandljeve kisline z urinom.
Benign hyperplasia and concomitant congestion of the upper urinary tract, chronic urinary tract infections or bladder stones 
• benigna hiperplazija prostate in sočasna obstrukcija zgornjih sečil, kronična okužba sečil ali kamni v mehurju;
OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF Doxazosin “Winthrop” 4 mg prolonged release tablets and associated names (see Annex I) 
SPLOŠNI POVZETEK ZNANSTVENEGA VREDNOTENJA ZDRAVILA Doxazosin “Winthrop” 4 mg tablete s podaljšanim sproščanjem in z njim povezanih imen (glejte Dodatek I)
The usual dose of Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]is one tablet taken as a single dose each day. 
Običajen odmerek zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena je ena tableta v obliki enega odmerka vsak dan.
Your Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]may affect your ability to drive or operate machinery, especially when you first start to take your tablets. 
Zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena lahko vpliva na sposobnost vožnje ali upravljanja strojev, zlasti na začetku jemanja tablet.
Rare side effects, seen in more than 1 in 10,000 patients but less than 1 out of 1,000, include low blood sugar levels, depression, feeling restless (agitation), pins and needles, blurred vision, stroke (cerebrovascular disturbance), swelling of the voice box, abdominal pain, diarrhoea, vomiting, jaundice, increased liver enzymes in the blood, rash, itching or reddening of the skin, impotence, painful, persistent erection of the penis and low body temperature (especially in the elderly). 
Med redkimi neželenimi učinki, ki so jih opazili pri več kot 1 bolniku od 10.000, vendar manj kot 1 bolniku od 1000, so nizke ravni sladkorja v krvi, depresija, nemir (agitacija), mravljinčenje, zamegljen vid, možganska kap (cerebrovaskularne motnje), otekanje grla, bolečina v trebuhu, driska, bruhanje, zlatenica, zvišane ravni jetrnih encimov v krvi, izpuščaj, srbenje ali rdečica kože, impotenca, boleča, vztrajna erekcija in nizka telesna temperatura (zlasti pri starejših bolnikih).
In patients taking Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]to treat high blood pressure (hypertension), the doxazosin works by relaxing the blood vessels so that the blood passes through them more easily and this helps to lower your blood pressure. 
Pri bolnikih, ki jemljejo zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena za zdravljenje visokega krvnega tlaka (hipertenzije), doksazosin deluje tako, da sprošča krvne žile, kar olajša pretok krvi skoznje in zniža krvni tlak.
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]should be used with care in patients with Diabetic Autonomic Neuropathy. 
Zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena je treba pri bolnikih z diabetično avtonomno nevropatijo uporabljati previdno.
Administration of Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]in hypertensive patients causes a clinically significant reduction in blood pressure as a result of a reduction in systemic vascular resistance. 
Uporaba zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena pri hipertenzivnih bolnikih povzroča klinično pomembno znižanje krvnega tlaka zaradi zmanjšanja sistemskega žilnega upora.
Common side effects, seen in more than 1 in 100 patients but less than 1in 10, include apathia muscle cramps, tiredness, a general feeling of being unwell or weakness, headache, sleepiness, problems with focussing your eyes, palpitations, chest pain, giddiness, dizziness, swelling, faintness or dizziness when standing up from a sitting or lying position (orthostatic dysregulation), shortness of breath, runny nose (rhinitis), constipation, indigestion, an increased desire or need to urinate and delayed ejaculation weakness (asthenia). 
Med pogostimi neželenimi učinki, ki so jih opazili pri več kot 1 bolniku od 100, vendar manj kot 1 bolniku od 10, so apatija, mišični krči, utrujenost, splošno slabo počutje ali šibkost, glavobol, zaspanost, težave z ostrino vida, razbijanje srca, bolečine v prsnem košu, vrtoglavica, omotica, otekanje, omedlevica ali vrtoglavica pri vstajanju iz sedečega ali ležečega položaja (ortostatska disregulacija), zasoplost, izcedek iz nosu (rinitis), zaprtje, prebavne motnje, povečana želja ali potreba po uriniranju in zapoznela ejakulacija, oslabelost (astenija).
- The active substance is doxazosin mesilate. 
- Zdravilna učinkovina je doksazosinijev mesilat.
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]should not be used during pregnancy unless clearly needed. 
Zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena ne smete uporabljati med nosečnostjo, razen če je nujno potrebno.
At steady-state, the relative bioavailability of doxazosin from Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]prolonged release tablets compared to immediate release form was 54% at the 4 mg dose and 59% at the 8 mg dose. 
V stanju dinamičnega ravnovesja je relativna biološka uporabnost doksazosina v zdravilu Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena 54 % relativne biološke uporabnosti doksazosina v tabletah s takojšnjim sproščanjem, pri odmerku 8 mg pa 59 %.
The pharmacokinetic properties of doxazosin in Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]prolonged release tablets lead to a minor variation in plasma levels. 
Farmakokinetične lastnosti doksazosina v zdravilu Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena so vzrok za manjše razlike pri koncentracijah v plazmi.
After oral administration of therapeutic doses, doxazosin in Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]prolonged release tablets is well absorbed with peak blood levels gradually reached at 6 to 8 hours after dosing. 
Po peroralnem jemanju terapevtskih odmerkov se doksazosin v zdravilu Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena dobro absorbira, najvišje koncentracije v plazmi pa so postopoma dosežene v 6 do 8 urah po odmerjanju.
Each prolonged-release tablet contains 4 mg doxazosin (as mesilate). 
2 KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsaka tableta s podaljšanim sproščanjem vsebuje 4 mg doksazosina (v obliki mesilata).
Throughout the recommended dosage range, Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]has only a minor or no effect on blood pressure in normotensive benign prostatic hyperplasia (BPH) patients. 
Znotraj priporočenega intervala odmerkov ima zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena pri normotenzivnih bolnikih z benigno hiperplazijo prostate (BPH) le manjši učinek na krvni tlak ali pa ga sploh nima.
Overflow bladder, anuria or progressive renal insufficiency History of oesophageal or gastrointestinal obstruction or decreased lumen diameter of the gastrointestinal tract 
• ezofagealna ali gastrointestinalna obstrukcija v anamnezi ali zmanjšan premer lumna prebavil.
PVC/PVDC/aluminium blister pack. 
6.5 Vrsta ovojnine in vsebina Pretisni omot iz PVC/PVDC/aluminija.
Do not take Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]if you are pregnant or breast-feeding. 
Zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena ne jemljite, če ste noseči ali če dojite.
Marketing Authorisation Holder and Manufacturer: Marketing Authorisation Holder: [To be completed nationally] 
Imetnik dovoljenja za promet z zdravilom in izdelovalec: Imetnik dovoljenja za promet z zdravilom: [Izpolni država članica]
In patients with hypertension, the decrease in blood pressure during treatment with Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]was similar in both the sitting and standing position. 
Pri bolnikih s hipertenzijo je bilo med zdravljenjem z zdravilom Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena znižanje krvnega tlaka v sedečem in stoječem položaju podobno.
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]work by relaxing the muscle around the bladder exit and prostate gland, which allows the urine to pass more easily. 
Zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena deluje tako, da sprošča mišice okoli izvodila mehurja in prostate, kar olajša uriniranje.
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]is not recommended for use in children and adolescents due to a lack of clinical experience. 
Uporaba zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena pri otrocih zaradi pomanjkanja kliničnih izkušenj ni priporočena.
Lactation. 
• dojenje.
Peak/trough ratio of Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]prolonged release tablets is less than half that of immediate release doxazosin tablets. 
Razmerje najvišjih koncentracij in koncentracij pred naslednjim odmerkom pri zdravilu Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena je manjše kot polovica razmerja pri tabletah doksazosina s takojšnjim sproščanjem.
Patients treated with immediate release doxazosin tablets against hypertension can be transferred to Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]prolonged release tablets and the dose titrated upwards as needed, while maintaining effect and tolerability. 
Bolniki, ki jemljejo tablete doksazosina s takojšnjim sproščanjem lahko preidejo na zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena.
Taking Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]with food and drink 
Jemanje zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena skupaj s hrano in pijačo
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]can be taken at any time of day, during or after meals. 
Zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena lahko jemljete kadar koli čez dan, s hrano ali po obroku.
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]can be taken with or without food. 
Zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena se lahko jemlje s hrano ali brez nje.
the CHMP has recommended the granting of the Marketing Authorisation(s) for which the Summary of Product Characteristics, labelling and package leaflet are set out in Annex III for Doxazosin “Winthrop” 4 mg prolonged release tablets and associated names (see Annex I). 
je CHMP za Doksazosin “Winthrop” 4 mg tablete s podaljšanim sproščanjem in z njim povezana imena (glejte Dodatek I) priporočil odobritev dovoljenj za promet z zdravilom, za katere so Povzetki glavnih značilnosti zdravila, označevanje in Navodila za uporabo opredeljeni v Dodatku III.
Patients with hepatic impairment: Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]should be given with particular caution to patients with evidence of impaired liver function. 
Bolniki z jetrno okvaro: Bolnikom z jetrno okvaro je treba zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena dajati posebno previdno.
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I] 
Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena [glejte Dodatek I] doksazosin
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]has moderate influence on the ability to drive and use machines, especially at the beginning of therapy. 
Zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena ima zmeren vpliv na sposobnost vožnje in upravljanja s stroji.
If you take more Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]than you should: 
Če ste vzeli večji odmerek zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena, kot bi smeli.
This is the maximum dose of Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]. 
To je največji odmerek zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena.
NAME OF THE MEDICINAL PRODUCT [See Annex I - To be completed nationally] Doxazosin STATEMENT OF ACTIVE SUBSTANCE(S) Each prolonged-release tablet contains 4 mg of doxazosin (as mesilate). 
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Vsaka tableta s podaljšanim sproščanjem vsebuje 4 mg doksazosina (v obliki mesilata).
1 WHAT DOXAZOSIN WINTHROP 4 MG PROLONGED RELEASE TABLETS AND ASSOCIATED NAMES [SEE ANNEX I]IS AND WHAT IT IS USED FOR 
1 KAJ JE ZDRAVILO DOXAZOSIN WINTHROP 4 MG TABLETE S PODALJŠANIM SPROŠČANJEM IN POVEZANA IMENA IN ZA KAJ GA UPORABLJAMO
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]can be taken with or after food. 
Zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena lahko jemljete s hrano ali po obroku.
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]should be administered with caution in patients with signs of mild to moderate hepatic impairment (see section 5.2). 
Pri bolnikih z manjšo do zmerno jetrno okvaro je treba zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena odmerjati previdno (glejte poglavje 5.2).
• if you have ever suffered an allergic reaction (e.g. itching, reddening of the skin or difficulty breathing) 
• če ste kdaj imeli alergijsko reakcijo (npr. srbenje, rdečico kože ali težave pri dihanju) na zdravilno učinkovino doksazosin ali katero koli zgoraj navedeno sestavino zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena;
What Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]is and what it is used for 
Kaj je zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena in za kaj ga uporabljamo
3 HOW TO TAKE DOXAZOSIN WINTHROP 4 MG PROLONGED RELEASE TABLETS AND ASSOCIATED NAMES [SEE ANNEX I] 
3 KAKO JEMATI ZDRAVILO DOXAZOSIN WINTHROP 4 MG TABLETE S PODALJŠANIM SPROŠČANJEM IN POVEZANA IMENA
Alternatively, breast-feeding must be stopped, if treatment with Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]is unavoidable. 
Če je zdravljenje z zdravilom Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena neizogibno, je treba dojenje prekiniti.
2 BEFORE YOU TAKE DOXAZOSIN WINTHROP 4 MG PROLONGED RELEASE TABLETS AND ASSOCIATED NAMES [SEE ANNEX I] 
1 IME ZDRAVILA Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena [glejte Dodatek I]
Always take Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]exactly as your doctor has told you. 
Pri jemanju zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena natančno upoštevajte zdravnikova navodila.
Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I]may be used in benign prostatic hyperplasia (BPH) patients who are either hypertensive or normotensive, as the blood pressure changes in normotensive patients are clinically insignificant. 
Spremembe krvnega tlaka pri normotenzivnih bolnikih so klinično nepomembne, zato se lahko zdravilo Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena uporablja pri hipertenzivnih in tudi pri normotenzivnih bolnikih z benigno hiperplazijo prostate (BPH - benign prostatic hyperplasia).
Take special care with Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I] 
Bodite posebno pozorni pri jemanju zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena:
Do not take Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I] 
Ne jemljite zdravila Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena:
How to take Doxazosin Winthrop 4 mg prolonged release tablets and associated names [See Annex I] 4. 
NAVODILO ZA UPORABO Doxazosin Winthrop 4 mg tablete s podaljšanim sproščanjem in povezana imena [glejte Dodatek I] (doksazosin)
8 MARKETING AUTHORISATION NUMBER 
8 ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET [Izpolni država članica]
The procedure started on 18 October 2007. 
Postopek se je začel dne 18. oktobra 2007.